Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been ...

An international team of researchers, including scientists of the University of Groningen, have now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides ...

Medications like zoledronic acid (Reclast ... while others damage kidney cells directly. Examples include aminoglycosides, vancomycin, acyclovir, and tenofovir (used in HIV treatment).

Telomir Pharma (NASDAQ: TELO) secured $3M in equity financing from Bayshore Trust, its largest shareholder, at $3 per share ...

Prevalence of UTIs in Indian population is estimated to be around 33%. Men have less than 15% chance of developing this ...

Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, presented 11 ...

A preclinical-stage biotech company developing therapeutics targeting aging-related diseases and drug-resistant infections.

Generated net FUROSCIX® revenue of $11.8 million in the first quarter of 2025 Formally launched FUROSCIX in second approved indication, Chronic Kidney Disease, in April 2025 Autoinjector on track for ...

Aminoglycosides are one of the categories of antibiotics most frequently used in treating several cattle diseases at the Central Cattle Breeding and Dairy Farm (CCBDF), Savar,Dhaka,Bangladesh.

The World Health Organization (WHO) on Thursday announced its support for weight-loss drugs in adults globally. The organization plans to back GLP-1s like Wegovy and Zepbound to treat obesity in ...

U.S. weight-loss drug prices exceed those in other developed countries Drugmakers say they support fairer cost-sharing across countries Some 40% of Americans estimated to have obesity Executive ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...